US poised to approve its first ‘biosimilar’ drug

Friday, January 9, 2015 - 10:30 in Health & Medicine

FDA panel recommends Sandoz’s copy of Amgen’s Neupogen

Read the whole article on Chemistry World

More from Chemistry World

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net